Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta‐analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-5491|32|12|1530-1540

ISSN： 0742-3071

Source： DIABETIC MEDICINE, Vol.32, Iss.12, 2015-12, pp. : 1530-1540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1221-1235

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of linagliptin added to metformin and sulphonylurea in Chinese patients with type 2 diabetes: a sub-analysis of data from a randomised clinical trial

By Zeng Zhengpei  

Current Medical Research and Opinion, Vol. 29, Iss. 8, 2013-08 ,pp. : 921-929

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

By Raz Itamar   Chen Yu   Wu Mei   Hussain Shehla   Kaufman Keith D.   Amatruda John M.   Langdon Ronald B.   Stein Peter P.   Alba Maria  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 537-550

Informa Healthcare

Access to resources Recommend Favorite

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 1462-8902, Iss. 10, 2015-10 ,pp. : 956-964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 10, 2015-10 ,pp. : 956-964

John Wiley & Sons Inc

Access to resources Recommend Favorite